NewsRx

Search our medical news database

Allergan, Inc.

Botox maker promotes Jeffrey Edwards to executive VP

Published in Healthcare Mergers, Acquisitions and Ventures Week, October 22nd, 2005

Allergan, Inc., (AGN) announced that Eric K. Brandt has resigned from Allergan, effective September 5, 2005, to accept a position as president and CEO of Avanir Pharmaceuticals (AVN).

Replacing Brandt will be Jeffrey L. Edwards, who will assume the position of Executive VP, finance and business development, chief financial officer.

Edwards has served as Allergan's Corporate VP, Corporate Development since 2002. Edwards has worked at Allergan since 1993, where he has held positions of increasing responsibility, including senior VP, tax, treasury and investor relations.

In that role, Edwards was instrumental in developing and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook